Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (14)
Jake Earl. (2019) Innovative Practice, Clinical Research, and the Ethical Advancement of Medicine. The American Journal of Bioethics 19:6, pages 7-18.
Read now
Read now
Elena Fountzilas, Rabih Said & Apostolia M. Tsimberidou. (2018) Expanded access to investigational drugs: balancing patient safety with potential therapeutic benefits. Expert Opinion on Investigational Drugs 27:2, pages 155-162.
Read now
Read now
Michael Hoerger. (2016) Right-to-try laws and individual patient “compassionate use” of experimental oncology medications: A call for improved provider-patient communication. Death Studies 40:2, pages 113-120.
Read now
Read now
Agnes Vitry, Tuan Nguyen, Vikky Entwistle & Elizabeth Roughead. (2015) Regulatory withdrawal of medicines marketed with uncertain benefits: the bevacizumab case study. Journal of Pharmaceutical Policy and Practice 8:1.
Read now
Read now
Seema K. Shah, David Wendler & Marion Danis. (2015) Examining the Ethics of Clinical Use of Unproven Interventions Outside of Clinical Trials During the Ebola Epidemic. The American Journal of Bioethics 15:4, pages 11-16.
Read now
Read now
David Magnus. (2014) Compassion and Research in Compassionate Use. The American Journal of Bioethics 14:11, pages 1-2.
Read now
Read now
P. Wicks & J. A. Heywood. (2014) Data Donation Could Power the Learning Health Care System, Including Special Access Programs. The American Journal of Bioethics 14:11, pages 27-29.
Read now
Read now
Udo Schuklenk. (2014) Access to Unapproved Medical Interventions in Cases of Catastrophic Illness. The American Journal of Bioethics 14:11, pages 20-22.
Read now
Read now
Christopher Lowry. (2014) Right Answer, Wrong Question: Special Access, Knowledge Generation, and Clinical Trial Legitimacy. The American Journal of Bioethics 14:11, pages 22-24.
Read now
Read now
Arthur Caplan & Alison Bateman-House. (2014) Compassion for Each Individual's Own Sake. The American Journal of Bioethics 14:11, pages 16-17.
Read now
Read now
Jess Rabourn & Richard S. Bedlack. (2014) SAPs: A Different Perspective. The American Journal of Bioethics 14:11, pages 19-20.
Read now
Read now
Anthony Vernillo. (2014) Special Access Programs and Clinical Research Trials—An Integration Long Overdue. The American Journal of Bioethics 14:11, pages 29-31.
Read now
Read now
Audrey Chapman. (2014) Proposal for Patient Obligations for Access to Unapproved Medical Interventions: Both Too Much and Not Enough. The American Journal of Bioethics 14:11, pages 25-26.
Read now
Read now
Michelle Roth-Cline & Robert Nelson. (2014) FDA Implementation of the Expanded Access Program in the United States. The American Journal of Bioethics 14:11, pages 17-19.
Read now
Read now
Articles from other publishers (27)
Zubin Master. (2023) The two-bucket problem of unproven stem cell interventions. Regenerative Medicine 18:1, pages 19-21.
Crossref
Crossref
Eline Bunnik & Marleen Eijkholt. 2023. Medical Research Ethics: Challenges in the 21st Century. Medical Research Ethics: Challenges in the 21st Century
367
384
.
Jeremiah Stout, Cambray Smith, Jan Buckner, Alex A. Adjei, Mark Wentworth, Jon C. Tilburt & Zubin Master. (2021) Oncologists’ reflections on patient rights and access to compassionate use drugs: A qualitative interview study from an academic cancer center. PLOS ONE 16:12, pages e0261478.
Crossref
Crossref
Monica E. Lemmon, Courtney J. Wusthoff, Renee D. Boss & Lisa Anne Rasmussen. (2021) Ethical considerations in the care of encephalopathic neonates treated with therapeutic hypothermia. Seminars in Fetal and Neonatal Medicine 26:5, pages 101258.
Crossref
Crossref
Jane Nielsen, Jenny Kaldor, Adam Irwin, Cameron Stewart & Dianne Nicol. (2021) Bespoke regulation for bespoke medicine? A comparative analysis of bioprinting regulation in Europe, the USA and Australia. Journal of 3D Printing in Medicine 5:3, pages 155-167.
Crossref
Crossref
Eline M. Bunnik & Nikkie Aarts. (2021) The Role of Physicians in Expanded Access to Investigational Drugs: A Mixed-Methods Study of Physicians’ Views and Experiences in The Netherlands. Journal of Bioethical Inquiry 18:2, pages 319-334.
Crossref
Crossref
SUMEL ASHIQUE & TAHAMINA KHATUN. (2021) COMPASSIONATE USE OF INVESTIGATIONAL DRUG DURING EMERGENCY CONDITIONS AND ASSOCIATED ETHICAL ASPECTS, CHALLENGES, AND BENEFITS. Asian Journal of Pharmaceutical and Clinical Research, pages 5-12.
Crossref
Crossref
Jan Borysowski & Andrzej Górski. (2020) Ethics framework for treatment use of investigational drugs. BMC Medical Ethics 21:1.
Crossref
Crossref
Jake Earl & David Wendler. (2020) Ethics of information‐gathering interventions in innovative practice. Internal Medicine Journal 50:12, pages 1583-1587.
Crossref
Crossref
Adam Greif & Martin Šurkala. (2020) Compassionate use of psychedelics. Medicine, Health Care and Philosophy 23:3, pages 485-496.
Crossref
Crossref
Michael Buckley & Collin O’neil. (2020) The Practice of Pharmaceutics and the Obligation to Expand Access to Investigational Drugs. The Journal of Medicine and Philosophy: A Forum for Bioethics and Philosophy of Medicine 45:2, pages 193-211.
Crossref
Crossref
Carolyn Riley Chapman, Jared Eckman & Alison S. Bateman‐House. (2020) Oversight of Right‐to‐Try and Expanded Access Requests for Off‐Trial Access to Investigational Drugs. Ethics & Human Research 42:1, pages 2-13.
Crossref
Crossref
Kirsten A. Riggan, Richard R. Sharp & Megan Allyse. (2019) Where Will We Draw the Line? Public Opinions of Human Gene Editing. Qualitative Health Research 29:12, pages 1823-1835.
Crossref
Crossref
Jan Borysowski & Andrzej Górski. (2019) Compassionate use of unauthorized drugs: Legal regulations and ethical challenges. European Journal of Internal Medicine 65, pages 12-16.
Crossref
Crossref
Stacey B. Lee & Alexandra Y. Murata. (2017) The Expanded Access Cure: A Twenty-First Century Framework for Companies. Journal of Business Ethics 156:1, pages 155-171.
Crossref
Crossref
David J. Cote. 2019. Ethics of Innovation in Neurosurgery. Ethics of Innovation in Neurosurgery
93
103
.
Seydina B Touré, Erika Kleiderman & Bartha M Knoppers. (2018) Bridging stem cell research and medicine: a learning health system. Regenerative Medicine 13:6, pages 741-752.
Crossref
Crossref
Eline M. Bunnik, Nikkie Aarts & Suzanne van de Vathorst. (2018) Little to lose and no other options: Ethical issues in efforts to facilitate expanded access to investigational drugs. Health Policy 122:9, pages 977-983.
Crossref
Crossref
Jan Borysowski, Abha Saxena, Alison Bateman-House, Marisa Papaluca, Joanna Różyńska, Agata Wnukiewicz-Kozłowska & Andrzej Górski. (2018) Expanded access: growing importance to public health. Journal of Epidemiology and Community Health 72:7, pages 557-558.
Crossref
Crossref
Philippe Calain. (2018) The Ebola clinical trials: a precedent for research ethics in disasters. Journal of Medical Ethics 44:1, pages 3-8.
Crossref
Crossref
Jan Borysowski, Hans-Jörg Ehni & Andrzej Górski. (2017) Ethics review in compassionate use. BMC Medicine 15:1.
Crossref
Crossref
David J. CoteNaci BalakJannick BrennumDaniel T. HolsgroveNeil KitchenHerbert KolendaWouter A. MoojenKarl SchallerPierre A. RobeTiit Mathiesen & Marike L. Broekman. (2017) Ethical difficulties in the innovative surgical treatment of patients with recurrent glioblastoma multiforme. Journal of Neurosurgery 126:6, pages 2045-2050.
Crossref
Crossref
Holger Langhof & Daniel Strech. 2017. Angewandte Ethik in der Neuromedizin. Angewandte Ethik in der Neuromedizin
95
105
.
Tim K. Mackey & Virginia J. Schoenfeld. (2016) Going “social” to access experimental and potentially life-saving treatment: an assessment of the policy and online patient advocacy environment for expanded access. BMC Medicine 14:1.
Crossref
Crossref
Kasper Raus. (2016) An analysis of common ethical justifications for compassionate use programs for experimental drugs. BMC Medical Ethics 17:1.
Crossref
Crossref
Andrzej Górski, Ryszard Międzybrodzki, Beata Weber-Dąbrowska, Wojciech Fortuna, Sławomir Letkiewicz, Paweł Rogóż, Ewa Jończyk-Matysiak, Krystyna Dąbrowska, Joanna Majewska & Jan Borysowski. (2016) Phage Therapy: Combating Infections with Potential for Evolving from Merely a Treatment for Complications to Targeting Diseases. Frontiers in Microbiology 7.
Crossref
Crossref
Wendy Lipworth & Renata Axler. (2016) Towards a bioethics of innovation. Journal of Medical Ethics 42:7, pages 445-449.
Crossref
Crossref